GAPDH and rheumatoid arthritis: These results show that survivin prevented the alterations in carbohydrate metabolism seen in the BIRC5hi CD4+ cells from patients with RA (Figure 1F) but did not alter the mRNA levels of HIF1A or its metabolic targets HK2, ALDOA, ENO1, and GAPDH (Figure S2A).